SPIRE HEALTHCARE GROUP PLC Financials Spire Healthcare Group plc Börse Stuttgart
Equities
S00
GB00BNLPYF73
Healthcare Facilities & Services
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.78 EUR | -0.71% |
|
-3.47% | 0.00% |
| May. 09 | Spire Healthcare touts strong trading, backs outlook | AN |
| May. 09 | Spire Healthcare Reiterates FY24 Guidance | MT |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 569.2 | 622.9 | 1,002 | 920.8 | 915.3 | 957.1 | - | - |
| Enterprise Value (EV) 1 | 899.2 | 1,687 | 2,065 | 2,037 | 915.3 | 2,122 | 2,088 | 2,015 |
| P/E ratio | 29.6 x | -2.66 x | -104 x | 109 x | 34.3 x | 22.2 x | 15 x | 11 x |
| Yield | 2.68% | - | - | 0.22% | 0.31% | 1.25% | 1.66% | 2.12% |
| Capitalization / Revenue | 0.58 x | 0.68 x | 0.91 x | 0.77 x | 0.67 x | 0.62 x | 0.59 x | 0.56 x |
| EV / Revenue | 0.92 x | 1.83 x | 1.87 x | 1.7 x | 0.67 x | 1.38 x | 1.28 x | 1.17 x |
| EV / EBITDA | 7.46 x | 10.5 x | 11.6 x | 10 x | 3.91 x | 7.89 x | 6.96 x | 6.05 x |
| EV / FCF | 12.4 x | 14.9 x | 18 x | 21.7 x | - | 21.1 x | 16.2 x | 13.3 x |
| FCF Yield | 8.07% | 6.7% | 5.55% | 4.61% | - | 4.75% | 6.17% | 7.55% |
| Price to Book | 0.61 x | 0.88 x | - | 1.25 x | - | 1.24 x | 1.17 x | 1.08 x |
| Nbr of stocks (in thousands) | 400,829 | 400,829 | 400,862 | 403,868 | 404,099 | 403,820 | - | - |
| Reference price 2 | 1.420 | 1.554 | 2.500 | 2.280 | 2.265 | 2.370 | 2.370 | 2.370 |
| Announcement Date | 3/5/20 | 3/4/21 | 3/3/22 | 3/2/23 | 2/29/24 | - | - | - |
1GBP in Million2GBP
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 980.8 | 919.9 | 1,106 | 1,198 | 1,359 | 1,539 | 1,632 | 1,720 |
| EBITDA 1 | 120.5 | 161.1 | 178.2 | 203.5 | 234 | 268.9 | 300.1 | 332.9 |
| EBIT 1 | 54.7 | 67.1 | 81.1 | 105.6 | 130.4 | 159.6 | 184.3 | 210.5 |
| Operating Margin | 5.58% | 7.29% | 7.33% | 8.81% | 9.6% | 10.37% | 11.29% | 12.24% |
| Earnings before Tax (EBT) 1 | 24.3 | -231 | -1.9 | 3.9 | 34.6 | 58.42 | 84.52 | 112 |
| Net income 1 | 19.1 | -233.9 | -9.7 | 8.6 | 27.3 | 43.75 | 64.79 | 88.72 |
| Net margin | 1.95% | -25.43% | -0.88% | 0.72% | 2.01% | 2.84% | 3.97% | 5.16% |
| EPS 2 | 0.0480 | -0.5840 | -0.0240 | 0.0210 | 0.0660 | 0.1070 | 0.1577 | 0.2156 |
| Free Cash Flow 1 | 72.6 | 113.1 | 114.5 | 93.9 | - | 100.8 | 129 | 152.1 |
| FCF margin | 7.4% | 12.29% | 10.35% | 7.83% | - | 6.55% | 7.9% | 8.84% |
| FCF Conversion (EBITDA) | 60.25% | 70.2% | 64.25% | 46.14% | - | 37.48% | 42.97% | 45.68% |
| FCF Conversion (Net income) | 380.1% | - | - | 1,091.86% | - | 230.41% | 199.03% | 171.42% |
| Dividend per Share 2 | 0.0380 | - | - | 0.005000 | 0.007000 | 0.0297 | 0.0393 | 0.0503 |
| Announcement Date | 3/5/20 | 3/4/21 | 3/3/22 | 3/2/23 | 2/29/24 | - | - | - |
1GBP in Million2GBP
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2019 S2 | 2022 S1 | 2023 S1 | 2023 S2 | 2024 S1 | 2024 S2 |
|---|---|---|---|---|---|---|
| Net sales 1 | 489.2 | 597.9 | 676.5 | 682.5 | 781 | 779 |
| EBITDA 1 | 56.8 | 105.8 | 117.9 | 116.1 | 135 | 131 |
| EBIT 1 | 24 | - | 67.8 | 62.6 | 81 | 76 |
| Operating Margin | 4.91% | - | 10.02% | 9.17% | 10.37% | 9.76% |
| Earnings before Tax (EBT) 1 | 7.6 | - | - | - | 30 | 24 |
| Net income 1 | 5.5 | - | - | 14.9 | 21 | 17 |
| Net margin | 1.12% | - | - | 2.18% | 2.69% | 2.18% |
| EPS 2 | 0.0140 | - | 0.0300 | 0.0360 | 0.0510 | 0.0420 |
| Dividend per Share | 0.0250 | - | - | - | - | - |
| Announcement Date | 3/5/20 | 9/8/22 | 9/14/23 | 2/29/24 | - | - |
1GBP in Million2GBP
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | 330 | 1,064 | 1,063 | 1,117 | - | 1,165 | 1,131 | 1,058 |
| Net Cash position 1 | - | - | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | 2.739 x | 6.605 x | 5.964 x | 5.487 x | - | 4.333 x | 3.77 x | 3.179 x |
| Free Cash Flow 1 | 72.6 | 113 | 115 | 93.9 | - | 101 | 129 | 152 |
| ROE (net income / shareholders' equity) | 2.3% | -2.51% | -4.04% | 2.36% | - | 5.8% | 8.13% | 10.3% |
| ROA (Net income/ Total Assets) | 0.96% | -0.94% | -1.32% | 0.77% | - | 1.9% | 2.76% | 3.86% |
| Assets 1 | 1,999 | 24,814 | 736.4 | 1,112 | - | 2,297 | 2,347 | 2,295 |
| Book Value Per Share 2 | 2.340 | 1.760 | - | 1.820 | - | 1.910 | 2.030 | 2.190 |
| Cash Flow per Share 2 | - | 0.4000 | 0.4600 | 0.4400 | - | 0.4700 | 0.5200 | 0.6100 |
| Capex 1 | 60.6 | 46.6 | 69.3 | 87.7 | 84.4 | 101 | 103 | 108 |
| Capex / Sales | 6.18% | 5.07% | 6.26% | 7.32% | 6.21% | 6.54% | 6.32% | 6.3% |
| Announcement Date | 3/5/20 | 3/4/21 | 3/3/22 | 3/2/23 | 2/29/24 | - | - | - |
1GBP in Million2GBP
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
2.37
GBP
Average target price
3.105
GBP
Spread / Average Target
+31.01%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -26.36% | 14.93B | |
| -1.80% | 11.81B | |
| +3.65% | 11.67B | |
| +8.83% | 10.68B | |
| +26.35% | 8.49B | |
| -8.21% | 7.3B | |
| +6.02% | 6.72B | |
| +9.84% | 6.48B | |
| +19.81% | 4.54B |
- Stock Market
- Equities
- SPI Stock
- S00 Stock
- Financials Spire Healthcare Group plc
